highly significantp < 0.001
In contrast, the Ad5-GP4 group, commercial vaccine group, and control group exhibited highly significant differences in antibody levels compared to the HPBS-GP4 group ( p < 0.001).
In contrast, the Ad5-GP4 group, commercial vaccine group, and control group exhibited highly significant differences in antibody levels compared to the HPBS-GP4 group ( p < 0.001).